Complete Guide to Cervical Cancer Prevention: Key Points on HPV Vaccine and Screening

Introduction

Cervical cancer is one of the most common malignant tumors in women, but it is also the only cancer with a clearly identified cause that can be prevented and cured at an early stage. The World Health Organization (WHO) has proposed the "90-70-90" targets: by 2030, 90% of girls should complete HPV vaccination by age 15, 70% of women should undergo high-performance screening at ages 35 and 45, and 90% of diagnosed patients should receive treatment. In China, there are approximately 110,000 new cases of cervical cancer annually, with about 60,000 deaths, and the trend is toward younger patients. Fortunately, through the HPV vaccine and cervical screening, we can minimize the risk entirely. This article provides a complete guide from vaccination to screening, offering a clear path whether you are in China or planning to visit.

1. HPV Vaccine: The First Line of Defense Against Cervical Cancer

HPV (Human Papillomavirus) is the primary cause of cervical cancer, with over 99% of cervical cancer cases linked to persistent infection with high-risk HPV types. Currently, there are three types of HPV vaccines available:

Bivalent vaccine: Targets HPV types 16/18, preventing approximately 70% of cervical cancer cases, suitable for women aged 9-45.

Quadrivalent vaccine: Adds HPV types 6/11 to the bivalent coverage, preventing 90% of genital warts, also covering ages 9-45.

Nonavalent vaccine: Covers HPV types 16/18/31/33/45/52/58, preventing about 90% of cervical cancer and various other HPV-related cancers, suitable for ages 9-45 (approved up to age 45 in mainland China, up to 26 in some countries).

Vaccination Timing: The optimal age for vaccination is 9-14 years, when the immune response is strongest, requiring only two doses. After age 15, three doses are needed (at 0, 2, and 6 months). Women who are married or sexually active can still receive the vaccine, but the effectiveness may be reduced due to potential prior infection with some HPV types. Vaccination Process: In mainland China, you need to bring your ID card or passport and make an appointment at a community health service center or an international hospital. The vaccine is typically administered in three doses over about 6 months. After vaccination, a 30-minute observation period is required. Common side effects include redness or pain at the injection site, which usually resolves within 2-3 days.

2. Cervical Screening: A Key Tool for Early Detection

Even after receiving the HPV vaccine, regular screening is still recommended because the vaccine does not cover all high-risk HPV types. Screening methods are mainly divided into two categories:

HPV DNA testing: Detects infection with high-risk HPV types, with high sensitivity, suitable for women over 30; those with negative results can be re-screened every 5 years.

Cervical cytology (TCT): Examines for abnormal cell morphology, suitable for women aged 21-29, recommended every 3 years. If both tests are combined, women aged 30-65 can be screened every 5 years.

Handling Abnormal Results: If HPV is positive but TCT is normal, closer follow-up is needed, with a repeat test after 12 months; if TCT is abnormal, further colposcopy and biopsy are required to determine if precancerous lesions are present. Cervical precancerous lesions (CIN) typically develop slowly, taking 5-10 years from infection to cancer, and with early detection and treatment, the cure rate approaches 100%.

3. Guide for International Patients to Receive Vaccination and Screening in China

MedBridge Shanghai provides international patients with one-stop cervical cancer prevention services, including vaccine appointments, screening packages, and follow-up care. The process is as follows:

Online Consultation: Submit your medical needs through Contact Us, and our medical advisors will respond within 24 hours to assess your age, medical history, and previous screening records.

Hospital Appointment: Based on your schedule, we coordinate vaccination clinics or gynecological screening centers at partner hospitals in Shanghai (such as Ruijin Hospital or the International Medical Center).

Vaccination and Screening: Upon arrival, a professional doctor will conduct a consultation, confirm there are no contraindications, administer the first vaccine dose, and you can also schedule TCT and HPV testing. Typically, all procedures can be completed on the same day.

Report Interpretation and Follow-up: Screening reports are available within 5-7 working days, and doctors will interpret the results via video or email and develop a follow-up plan for your next check-up.

Cost Reference: The nonavalent vaccine costs approximately 1300-1500 RMB per dose (about 4000 RMB for three doses), and the screening package (TCT + HPV) costs about 500-800 RMB. For a personalized quote, you can use the Cost Estimator.

4. Common Misconceptions About Cervical Cancer Prevention

Misconception 1: Only sexually active women need vaccination. In fact, the vaccine is most effective for women who have not been infected with HPV, so even those without sexual activity can and should be vaccinated.

Misconception 2: No need for screening after vaccination. The vaccine does not prevent all HPV types, so screening remains essential.

Misconception 3: HPV infection means cancer. About 80% of women will contract HPV at some point in their lives, but most infections are cleared by the immune system within 1-2 years; only persistent infection may progress to cancer.

Misconception 4: One screening is enough for life. Screening frequency should be adjusted based on age and results and should not be discontinued arbitrarily.

Recommendations for International Patients

Get Vaccinated Early: If you are aged 9-14, arrange vaccination immediately; if you are over 26, the bivalent or quadrivalent vaccine is still effective, and mainland China allows vaccination up to age 45, so seize the opportunity.

Screen Regularly: Start TCT screening at age 21, combine with HPV testing after age 30, and follow your doctor's recommended frequency.

Choose Reliable Institutions: When seeking medical care in China, prioritize internationally certified hospitals partnered with MedBridge to ensure authentic vaccines, advanced screening equipment, and bilingual report interpretation.

Monitor Your Symptoms: Symptoms such as contact bleeding or abnormal discharge may signal cervical lesions; seek medical attention promptly.

Cervical cancer is preventable, and the key lies in action. If you plan to come to Shanghai for vaccination or screening, feel free to explore details through Medical Services or directly Contact Us to make an appointment. MedBridge will provide full support to help you safeguard your health.